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Introduction {#sec005}
============

Dengue is the most important arboviral disease globally, with an estimated 390 million dengue infections per year \[[@pntd.0008118.ref001]\] and causes an enormous economic burden to governments and households \[[@pntd.0008118.ref002]\]. The number of deaths due to dengue is increasing in recent years \[[@pntd.0008118.ref003]\]. It has been reported that over 3.9 billion people in 128 countries are at risk of dengue infection \[[@pntd.0008118.ref004]\]. Climatic factors affect the occurrence of dengue by impacting on the life cycle and transmission of dengue viruses, as well as the growth and survival of dengue vectors (i.e., *Aedes aegypti* and *Aedes albopictus*) \[[@pntd.0008118.ref005]\]. Hence, the association between climatic factors and dengue has been widely researched \[[@pntd.0008118.ref005]\]. For example, Li et al. have observed that climate-driven variation in mosquito density could predict the spatiotemporal dynamics of dengue in China \[[@pntd.0008118.ref006]\].

Climate change is occurring and affecting human health and wellbeing \[[@pntd.0008118.ref007]\]. As climate change continues, the global surface temperature will increase and the pattern of rainfall will change \[[@pntd.0008118.ref008]\], which will affect the environmental suitability for the growth and survival of dengue viruses and mosquitoes, and may subsequently change the burdens of dengue globally, nationally, and locally. There has been an increasing number of studies projecting the future disease burden of dengue, epidemic potential of dengue cases, geographical distribution of dengue cases, or population exposed to climatically suitable areas of dengue under climate change scenarios \[[@pntd.0008118.ref009]--[@pntd.0008118.ref020]\]. Nevertheless, appreciable heterogeneity exists in these projections in terms of modelling approaches used and future scenarios adopted. Messina et al. have assembled the existing studies projecting the global future of dengue under climate change scenarios and have discussed the popular methods used in these studies \[[@pntd.0008118.ref021]\]. However, regional or local studies were not included in the review of Messina et al.

In the present study, we attempted to review all available studies which projected the future disease burden of dengue, epidemic potential of dengue cases, geographical distribution of dengue cases, or population exposed to climatically suitable areas of dengue (hereinafter called "the future of dengue") under climate change scenarios, identify the uncertainties in this field and propose the future research needs.

Methods {#sec006}
=======

Data sources {#sec007}
------------

Empirical studies projecting the future of dengue under climate change scenarios published up to 30^th^ June 2019 were retrieved using PubMed, ProQuest, ScienceDirect, Scopus and Web of Science. The references of the identified papers were examined visually to make sure that all eligible papers were included in the final review.

Inclusion criteria {#sec008}
------------------

We restricted the search to peer-reviewed papers written in English. Our primary search used the following U.S. National Library of Medicine\'s Medical Subject Headings (MeSH terms) and keywords: "dengue", "climate", "prediction", "projection", "forecast", and "predicting". Eligibility included those papers which projected the future disease burden of dengue, epidemic potential of dengue cases, geographical distribution of dengue cases, or population exposed to climatically suitable areas of dengue under climate change scenarios around the globe or in one country/city using at least one climate change scenario. Climate change scenario is defined as a description of the future change in climate under concrete assumptions on the future growth of greenhouse gas (GHG) and on other factors which may impact future climate. The most widely used climate change scenarios are those developed by the Intergovernmental Panel on Climate Change (IPCC). In the IPCC's Fourth Assessment Report, three climate change scenarios detailed in the Special Report on Emissions Scenarios (SRES) were B1, A1B, and A2 \[[@pntd.0008118.ref022]\]. In the IPCC's Fifth Assessment Report, the emissions scenarios were called Representative Concentration Pathways (RCPs), and the four RCPs were RCP2.6 (low emission scenario), RCP4.5 and 6.0 (intermediate emission scenarios), and RCP8.5 (high emission scenario) \[[@pntd.0008118.ref008]\]. Although the presence of vectors is essential for the occurrence of dengue cases, published papers solely projecting the future distribution of dengue mosquitoes were not included in this review because the main outcome-of-interest of this review is human health.

Results {#sec009}
=======

We identified 2,449 articles in the initial search, and 16 of them entered the final review according to the inclusion criteria ([Fig 1](#pntd.0008118.g001){ref-type="fig"}). The specific characteristics of these 16 articles are presented in [Table 1](#pntd.0008118.t001){ref-type="table"}.

![The flow chart of literature selection process.](pntd.0008118.g001){#pntd.0008118.g001}
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###### Characteristics of the studies projecting the burden or geographical distribution of dengue under climate change scenarios.

![](pntd.0008118.t001){#pntd.0008118.t001g}

  ---------------------------- --------------------------------------------------------------------------------------- ----------------- --------------------------- -------------------------------------------------------------------------- ----------------------------------------- -------------------- -----------------------------------------------------------------------------------------------
  Study                        Setting                                                                                 Baseline period   Projection period           Climate change scenarios                                                   Spatial resolution                        Modelling approach   Outcomes

  Acharya et al. 2018          Nepal                                                                                   1950--2000        2050 and 2070               RCP2.6, RCP6.0 and RCP8.5                                                  30 arc second                             Mechanistic model    Population exposed to climatically suitable areas of dengue

  Bambrick et al. 2009         Australia                                                                               1961--1990        2100                        Four climate change scenarios produced by CSIRO                            Not given                                 Correlative model    Distribution of dengue cases and people living in regions of high risk of dengue transmission

  Banu et al. 2014             Dhaka, Bangladesh\                                                                      2000--2010        2100                        Monthly temperature increases by 1, 2 and 3.3°C in 2100 relative to 2010   Not given                                 Correlative model    Annual number of dengue cases

  Bouzid et al. 2014           Europe                                                                                  1961--1990        2011--2040,\                A1B                                                                        10 km \* 10 km                            Correlative model    Number and geographical distribution of dengue cases
                                                                                                                                         2041--2070,\                                                                                                                                                          
                                                                                                                                         2071--2100\                                                                                                                                                           

  Butterworth et al. 2017      23 locations of the US                                                                  1961--1990        2045--2065                  A1B                                                                        1.3^o^ -- 3.9^o^                          Mechanistic model    Number of dengue cases

  Study                        Setting                                                                                 Baseline period   Projection period           Climate change scenarios                                                   Spatial resolution                        Modelling approach   Outcomes

  Colon-Gonzalez et al. 2013   Mexico                                                                                  1970--1999        2030, 2050, and 2080        A1B, A2 and B1                                                             Not given                                 Correlative model    The average value and distribution of annual dengue incidence

  Fan et al. 2019              China                                                                                   1981--2016        2020, 2030, 2050 and 2100   RCP2.6, RCP4.5, RCP6.0 and RCP8.5                                          0.5^o^ \* 0.5^o^                          Mechanistic model    Distribution of dengue cases

  Lee et al. 2018              Korea                                                                                   2012--2016        2020--2099                  RCP2.6, RCP4.5, RCP6.0 and RCP8.5                                          Not given                                 Mechanistic model    Potential risk of dengue outbreaks

  Li et al. 2017               Guangzhou, China                                                                        1998--2014        2020--2070                  RCP2.6 and RCP8.5                                                          Not given                                 Correlative model    Number of dengue cases

  Liu-Helmersson et al. 2016   10 European cities                                                                      1901--1930,\      2070--2099                  RCP2.6, RCP4.5, RCP6.0 and RCP8.5                                          0.25^o^ \* 0.25^o^                        Mechanistic model    The seasonal peak and time window for dengue epidemic potential
                                                                                                                       1984--2013                                                                                                                                                                              

  Williams et al. 2016         Four cities (Brisbane, Cairns, Rockhampton, and Townsville) in Queensland, Australia.   1990--2011        2046--2064                  A2 and B1                                                                  Not given                                 Mechanistic model    Probability of dengue outbreaks and epidemic potential

  Study                        Setting                                                                                 Baseline period   Projection period           Climate change scenarios                                                   Spatial resolution                        Modelling approach   Outcomes

  Astrom et al. 2012           Globe                                                                                   1961--1990        2050                        A1B                                                                        0.5^o^ \* 0.5^o^                          Correlative model    Population at risk of dengue and its distribution

  Hales et al. 2002            Globe                                                                                   1961--1990        2050 and 2080               IS92a and IS92f                                                            0.5^o^ \* 0.5^o^                          Correlative model    Population at risk of dengue

  Martens et al. 1997          Globe                                                                                   1931--1980        2050                        GFDL89, UKTR, and ECHAM1-A                                                 Not given                                 Mechanistic model    Epidemic potential of dengue cases

  Messina et al. 2019          Globe                                                                                   1960--2015        2020, 2050 and 2080         RCP4.5, RCP6.0 and RCP8.5                                                  5 km \* 5 km                              Mechanistic model    Environmental suitability for dengue virus and population at risk of dengue

  Patz et al. 1998             Globe                                                                                   1931--1980        2050                        Three GCMs                                                                 250 km horizontally and 1 km vertically   Mechanistic model    Dengue average annual epidemic potential
  ---------------------------- --------------------------------------------------------------------------------------- ----------------- --------------------------- -------------------------------------------------------------------------- ----------------------------------------- -------------------- -----------------------------------------------------------------------------------------------

Local, national or regional studies {#sec010}
-----------------------------------

Eleven of the 16 studies included in the final review projected the future of dengue at the local, national, or regional level ([Table 1](#pntd.0008118.t001){ref-type="table"}). Specifically, the research settings of these studies were Australia \[[@pntd.0008118.ref011], [@pntd.0008118.ref020]\], Bangladesh \[[@pntd.0008118.ref012]\], China \[[@pntd.0008118.ref015], [@pntd.0008118.ref017]\], Europe \[[@pntd.0008118.ref023], [@pntd.0008118.ref024]\], Korea \[[@pntd.0008118.ref025]\], Mexico \[[@pntd.0008118.ref014]\], Nepal \[[@pntd.0008118.ref009]\], and the US \[[@pntd.0008118.ref013]\]. These studies were largely heterogeneous in five key aspects. First, the baseline period used varied: three studies used 1961--1990 as the baseline period \[[@pntd.0008118.ref011], [@pntd.0008118.ref013], [@pntd.0008118.ref023]\], but the baseline periods used in the other eight studies varied. The inconsistency in the baseline period employed in different studies renders it difficult to directly compare the projection results across these studies. Second, the projection period also varied among studies: five studies used one year (e.g., 2100) or a couple of different years (e.g., 2050 and 2070) as the projection period \[[@pntd.0008118.ref009], [@pntd.0008118.ref011], [@pntd.0008118.ref012], [@pntd.0008118.ref014], [@pntd.0008118.ref015]\], and the other six studies used a consecutive period of time (e.g., 2070--2090) as the projection period \[[@pntd.0008118.ref013], [@pntd.0008118.ref017], [@pntd.0008118.ref020], [@pntd.0008118.ref023]--[@pntd.0008118.ref025]\]. The formation of a wide consensus on the use of projection periods (e.g. short-term (2030), middle-term (2050) and long-term (2100)) would facilitate the comparison of future study results. Third, the climate change scenarios used varied: four studies conducted in Australia \[[@pntd.0008118.ref020]\], Europe \[[@pntd.0008118.ref023]\], Mexico \[[@pntd.0008118.ref014]\], and the US \[[@pntd.0008118.ref013]\] used A1B, A2 and/or B1 as the climate change scenarios, and five studies conducted in China \[[@pntd.0008118.ref015], [@pntd.0008118.ref017]\], Europe \[[@pntd.0008118.ref024]\], Korea \[[@pntd.0008118.ref025]\] and Nepal \[[@pntd.0008118.ref009]\] used RCPs to project the future of dengue. The study by Bambrick et al. used the climate change scenarios produced by CSIRO (the Commonwealth Scientific and Industrial Research Organisation of Australia) \[[@pntd.0008118.ref011]\] and the study of Banu et al. used the climate change scenarios assuming that the monthly temperature in 2100 will increase by 1, 2 or 3.3°C relative to 2010 \[[@pntd.0008118.ref012]\]. Fourth, the modelling approach used: there are generally two types of models used in projecting the future of dengue, i.e., mechanistic model and correlative model \[[@pntd.0008118.ref021]\]. The strengths and limitations of these two modelling approaches can be found in the previous review papers \[[@pntd.0008118.ref021], [@pntd.0008118.ref026]\]. In the 11 studies which projected the future of dengue locally, nationally, or regionally, six used mechanistic modelling approach \[[@pntd.0008118.ref009], [@pntd.0008118.ref013], [@pntd.0008118.ref015], [@pntd.0008118.ref020], [@pntd.0008118.ref024], [@pntd.0008118.ref025]\], and the other five used correlative modelling approach \[[@pntd.0008118.ref011], [@pntd.0008118.ref012], [@pntd.0008118.ref014], [@pntd.0008118.ref017], [@pntd.0008118.ref023]\]. Last, the outcome variable also differed: five studies projected the future number of dengue cases \[[@pntd.0008118.ref012]--[@pntd.0008118.ref014], [@pntd.0008118.ref017], [@pntd.0008118.ref023]\], four studies projected the future spatial distribution of dengue cases/incidence \[[@pntd.0008118.ref011], [@pntd.0008118.ref014], [@pntd.0008118.ref015], [@pntd.0008118.ref023]\], two studies projected the future population exposed to climatically suitable areas of dengue or future population living in regions of high risk of dengue transmission \[[@pntd.0008118.ref009], [@pntd.0008118.ref011]\], and three studies projected the future dengue epidemic potential \[[@pntd.0008118.ref020], [@pntd.0008118.ref024], [@pntd.0008118.ref025]\].

Global studies {#sec011}
--------------

At 30^th^ June 2019, there were five studies which projected the future of dengue at the global scale ([Table 1](#pntd.0008118.t001){ref-type="table"}) \[[@pntd.0008118.ref010], [@pntd.0008118.ref016], [@pntd.0008118.ref018], [@pntd.0008118.ref019], [@pntd.0008118.ref027]\]. Interestingly, the period 1961--1990 was also used as the baseline period in two of these five studies \[[@pntd.0008118.ref010], [@pntd.0008118.ref016]\], and 1931--1980 was used as the baseline period in another two studies \[[@pntd.0008118.ref018], [@pntd.0008118.ref019]\]. Regarding the projection period, all of the five studies used 2050 or a couple of years including 2050 and 2080 as the projection period to project the future of dengue globally. The climate change scenarios employed in these global studies varied from one to another, and, as some studies were conducted before SRES or RCPs were introduced, they used some older climate change scenarios (e.g., GFDL89 \[[@pntd.0008118.ref018]\]). In terms of the outcome variables used, three of these studies projected the future global population at risk of dengue and its spatial distribution \[[@pntd.0008118.ref010], [@pntd.0008118.ref016], [@pntd.0008118.ref027]\], two projected the spatial pattern of dengue epidemic potential globally \[[@pntd.0008118.ref018], [@pntd.0008118.ref019]\], and one projected the spatial pattern of environmental suitability for dengue virus globally \[[@pntd.0008118.ref027]\].

Discussion {#sec012}
==========

Progress {#sec013}
--------

As the transmission of dengue involves dengue viruses, vectors, and susceptible people, to understand the precise relationship between climate and dengue transmission is not a trivial task \[[@pntd.0008118.ref006], [@pntd.0008118.ref028]\]. Further, projecting the future of dengue under climate change scenarios requires not just a good understanding of the association between climate and dengue but also comprehensive knowledge on future changes in climate and other factors (e.g. demographic change). Nevertheless, much progress has been made in this field. First, there is a growing consensus on using "population exposed to climatically suitable areas of dengue" or "epidemic potential of dengue cases" as the outcome variable in the projection \[[@pntd.0008118.ref009], [@pntd.0008118.ref024], [@pntd.0008118.ref027]\], instead of projecting the absolute number of future dengue cases. Second, with the advent of the multiple climate change scenarios introduced by IPCC covering the "best case scenario" and the possible "worst case scenario" \[[@pntd.0008118.ref008], [@pntd.0008118.ref022]\], the selection of climate change scenarios has become more consistent across different studies. Third, the presence of dengue vectors is pivotal for the transmission of dengue, but projecting the distribution of dengue vectors is challenging partially due to the unavailability of rich data on the present distribution of dengue vectors. Nevertheless, there have been a few attempts which incorporated findings on the current and future distributions of dengue vectors into the projection of dengue future \[[@pntd.0008118.ref029]--[@pntd.0008118.ref031]\]. Kraemer et al. have investigated the past and projected future spread of *A*. *aegypti* and *A*. *albopictus* globally \[[@pntd.0008118.ref030]\], and based on this work, Messina et al. have presented the current and future global population at risk of dengue \[[@pntd.0008118.ref027]\].

Uncertainties {#sec014}
-------------

Despite the progresses made in the projection of dengue future, many uncertainties remain to be resolved. First, sociodemographic factors play an appreciable role in the transmission of dengue, and incorporating sociodemographic factors in the projection of dengue future remains a challenge. A salient example is the relationship between travel and the transmission of dengue \[[@pntd.0008118.ref032]--[@pntd.0008118.ref034]\]. In 2016, there were more than 1.2 billion international tourists and this number is still growing \[[@pntd.0008118.ref035]\], raising concerns about the appreciable role that travel (particularly international travel \[[@pntd.0008118.ref036]\]) may play in the future transmission of dengue. Second, increasing temperature has been widely used as the indicator of climate change in the prior studies projecting the future of dengue, with rainfall and humidity being under-researched. Hales et al. reported that vapour pressure, an index which incorporates temperature and humidity, is the climate indicator which predicts the presence of dengue most accurately \[[@pntd.0008118.ref016]\]. However, the associations of different climatic factors with the transmission of dengue are complex and sometimes behave in a non-linear manner \[[@pntd.0008118.ref005], [@pntd.0008118.ref037]\]. Third, the crucial drivers behind the presence or absence of dengue vectors include, but are not limited to, climate or vector-control programs \[[@pntd.0008118.ref038]\], and other fundamental drivers remain to be unveiled. Fourth, why dengue transmission occurs in some regions with ideal environment and vectors, but not in other similar regions, remains mysterious.

Future research needs {#sec015}
---------------------

Accurately projecting the future of dengue under the context of climate change would help governments and public health officials take timely and pre-emptive actions to protect the public from dengue in the future. There are several knowledge gaps that need to be filled in this field. First, incorporating the most important sociodemographic factors (e.g., travel and demographic change) into the projections would yield a more accurate estimate of dengue future \[[@pntd.0008118.ref025]\]. Second, in some regions, temperature might not be the most significant climatic factor associated with the transmission of dengue \[[@pntd.0008118.ref039], [@pntd.0008118.ref040]\]. Identifying the locally important climatic factor and conducting precise projection at the local level is warranted. Third, it is of great significance to explore the non-climatic drivers behind the presence of *A*. *aegypti and A*. *albopictus*, and also to identify the crucial factors triggering the transmission of dengue in those climatically suitable regions. Fourth, some dengue control strategies may be effective in curbing its spread in some areas \[[@pntd.0008118.ref041]\]. As more evidence of their effectiveness accumulates (e.g., *Wolbachia* \[[@pntd.0008118.ref042], [@pntd.0008118.ref043]\]), such strategies need to be taken into account in dengue projections as some high risk regions for transmission may become low risk due to vector control capacity \[[@pntd.0008118.ref044]\]. Fifth, routine communication between the research community and policy makers on the local key drivers of dengue transmission is still deficient, calling for concerted efforts to be made in the future.

Limitations of this review {#sec016}
--------------------------

Several limitations of this review should be acknowledged. First, the different outcomes used in the existing studies projecting the future of dengue under climate change scenarios restricted us to quantitatively pool the findings. Second, understanding the future distribution of dengue vectors is an essential step in adequately understanding the future of dengue, but those studies solely projecting the future distribution of dengue vectors under climate change scenarios were not included in this review due to the focus of this review being on human health. Third, specific methodological issues in projecting the future of dengue (e.g., proper control of confounders) worth exploring but were not comprehensively elucidated in this review because some published review papers have discussed these issues to some extent.

Conclusion {#sec017}
----------

As climate change proceeds, population exposed to areas with suitable environment for the transmission of dengue may change. There is an increasing number of studies which projected the future of dengue under climate change scenarios. Identifying the non-climatic drivers behind the presence/absence of dengue vectors and the pivotal factors triggering the transmission of dengue in those climatically suitable areas is an important next step. In addition to future projections accounting for alternative climate change scenarios, benefit would come from considering different control scenarios (e.g., programs incorporating Wolbachia). This would not only improve projection realism but would also act as an impetus for establishing researchers and policy makers' consensus on provisions to mitigate future dengue.

Supporting information {#sec018}
======================
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